Institute of Biomedical Research Corp

Company Profile

Institute of Biomedical Research Corp had its IPO on under the ticker symbol MRES.

The company operates in the Healthcare sector and Biotechnology industry. Institute of Biomedical Research Corp has a staff strength of 0 employees.

Stock update

Shares of Institute of Biomedical Research Corp opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.

This is a -6.25% slip from the previous day's closing price.

A total volume of 1,424,594 shares were traded at the close of the day’s session.

In the last one week, shares of Institute of Biomedical Research Corp have increased by +19.68%.

Institute of Biomedical Research Corp's Key Ratios

Institute of Biomedical Research Corp has a market cap of $1.49 million, indicating a price to book ratio of 0.6859 and a price to sales ratio of 0.

In the last 12-months Institute of Biomedical Research Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Institute of Biomedical Research Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Institute of Biomedical Research Corp’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, Institute of Biomedical Research Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Institute of Biomedical Research Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-10.92 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Institute of Biomedical Research Corp’s profitability.

Institute of Biomedical Research Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.1355. Its price to sales ratio in the trailing 12-months stood at 0.

Institute of Biomedical Research Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$6.14 million

Total Liabilities

$3.80 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Institute of Biomedical Research Corp ended 2024 with $6.14 million in total assets and $0 in total liabilities. Its intangible assets were valued at $6.14 million while shareholder equity stood at $2.34 million.

Institute of Biomedical Research Corp ended 2024 with $0 in deferred long-term liabilities, $3.80 million in other current liabilities, 915789.00 in common stock, $-55579632.00 in retained earnings and $951440.00 in goodwill. Its cash balance stood at $2.23 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Institute of Biomedical Research Corp’s total current assets stands at $2.56 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $188642.00 compared to accounts payable of $1.84 million and inventory worth $0.

In 2024, Institute of Biomedical Research Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Institute of Biomedical Research Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.02

52-Week High

$0.0367

52-Week Low

$0.0069

Analyst Target Price

$

Institute of Biomedical Research Corp stock is currently trading at $0.02 per share. It touched a 52-week high of $0.0367 and a 52-week low of $0.0367. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.02 and 200-day moving average was $0.01 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.